Search SciPol

Brought to you by
October
30

Meeting: NCI Frederick National Laboratory Advisory Committee

  • Government
  • Agency
  • Genetics/Genomics

The Frederick National Laboratory for Cancer Research (FNLCR), within the National Institutes of Health's National Cancer Institute, will hold the 13th Regular Meeting of the Frederick National Laboratory Advisory Committee (FNLAC).

October
25

Meeting: 2017 NIH Regional Seminar – Program Funding and Grants Administration

  • Agency
  • Genetics/Genomics
  • Neuroscience

The National Institutes of Health (NIH)'s Regional Seminar serves the NIH mission of providing education and training for the next generation of biomedical and behavioral scientists. The seminar and optional workshops are appropriate for those who are new to working with the NIH grants process – administrators, new and early stage investigators, researchers, graduate students, etc.

October
24

Meeting: Interagency Autism Coordinating Committee

  • Government
  • Agency
  • Neuroscience

The Interagency Autism Coordinating Committee (IACC) will hold a public meeting to discuss business, agency updates, and issues related to autism spectrum disorder research and services activities.

October
23

Meeting: VA Geriatrics and Gerontology Advisory Committee

  • Government
  • Agency
  • Neuroscience

The Department of Veterans Affairs (VA) announces a meeting of the Geriatrics and Gerontology Advisory Committee. The meeting will feature presentations and discussions on Veterans Health Administration efforts regarding dementia and program advances in palliative care.

October
19

Meeting: Federal Energy Regulatory Committee (FERC)

  • Government
  • Agency
  • Energy

A Commission meeting will be held in the Commission Meeting Room (Room 2C) at the Federal Energy Regulatory Commission (FERC) Headquarters, 888 First St. N.E., Washington, D.C. 20426. The meeting is open to the public, and a free live webcast is available. All webcasts are archived for 3 months.

October
17

Meeting: HHS Secretary’s Advisory Committee on Human Research Protections

  • Agency
  • Genetics/Genomics
  • Neuroscience

The Secretary’s Advisory Committee on Human Research Protections (SACHRP) shall provide expert advice and recommendations to the Secretary, through the Assistant Secretary for Health (ASH), on issues and topics pertaining to or associated with the protection of human research subjects. The...

October
12

Meeting: FDA Cellular, Tissue, and Gene Therapies Advisory Committee

  • Government
  • Agency
  • Genetics/Genomics

The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Cellular, Tissue, and Gene Therapies Advisory Committee (CTGTAC). The general function of the committee is to provide advice and recommendations to the Agency on FDA's regulatory issues. The meeting will be open to the public.

October
11

Webinar: CDC-NIH Precision Medicine and Health Disparities

  • Government
  • Agency
  • Genetics/Genomics
  • Neuroscience

The Precision Medicine and Population Health Interest Group in the Division of Cancer Control and Population Sciences at the National Cancer Institute (NCI), the National Institutes for Health Genomics and Health Disparities Interest Group, and the CDC Office of Public Health Genomics invite you to a special one-hour online webinar that explores the intersection of genomics, precision medicine and health disparities.

October
11

Workshop: NASEM Advancing Therapeutic Development for Pain and Opioid Use Disorders through Public-Private Partnerships

  • Government
  • Agency
  • Science
  • Other
  • Neuroscience

The Board on Health Sciences Policy within the National Academies of Sciences, Engineering, and Medicine (NASEM) announces a workshop held by the Forum on Neuroscience and Nervous System Disorders. The workshop will bring together key stakeholders to 1) advance the discussions that emerge from the three National Institutes of Health meetings scheduled in June and July 2017 to address the opioid epidemic, and 2) examine potential implementation barriers and opportunities related to the proposed approaches discussed.

October
10

Workshop: FDA-AACR Liquid Biopsies in Oncology Drug and Device Development Part II

  • Government
  • Agency
  • Genetics/Genomics
  • Nanotechnology
  • Neuroscience

This workshop will examine the regulatory challenges in adopting liquid biopsy technology for early detection, disease monitoring, and the potential use as surrogate end point markers for drug development.

Pages